Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

NCT00917761 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Entecavir and peginterferon (Pegasys) (52 weeks)
DRUG: Peginterferon (Pegasys) (96 weeks)
DRUG: Peginterferon (Pegasys) (48 weeks)

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]